9:22 AM
Leo Group India
| ||
| Kinex Pharmaceuticals Appoints Dr. Jean-Pierre Sommadossi to the Board of ... Sacramento Bee By Kinex Pharmaceuticals, LLC BUFFALO, NY, June 5, 2012 -- /PRNewswire/ -- Kinex Pharmaceuticals, LLC announced today that Dr. David Hsia has elected to retire from the Board of Directors but will continue to support the company as a Senior Advisor to ... See all stories on this topic » | ||
| US court revives KV Pharmaceutical investor suit Reuters India By Nate Raymond (Reuters) - Investors can continue to bring claims against KV Pharmaceutical Co for making false or misleading statements to the US Food and Drug Administration, a federal appeals court ruled on Monday. The 8th Circuit Court of Appeals ... See all stories on this topic » | ||
| KV Pharmaceutical Must Face Suit Over Quality Assurances Bloomberg KV Pharmaceutical Co. (KV/A) must face an investor lawsuit claiming the company and its executives made misleading statements about its compliance with federal quality- control standards, a US appeals court ruled. Led by public employee pension plans ... See all stories on this topic » | ||
| JHP Pharmaceuticals to Produce Clinical and Commercial Supply of an Innovative ... MarketWatch (press release) PARSIPPANY, NJ, June 5, 2012 /PRNewswire via COMTEX/ -- JHP Pharmaceuticals, a provider of global contract manufacturing services for sterile products has entered into an agreement with an undisclosed pharmaceutical company to produce clinical and ... See all stories on this topic » | ||
| Celator(R) Pharmaceuticals Announces Presentations of Positive Survival ... MarketWatch (press release) Celator Pharmaceuticals today announced positive survival analyses from two completed clinical trials of CPX-351 (cytarabine:daunorubicin) Liposome Injection in acute myeloid leukemia (AML). A subset analysis of data from a randomized Phase 2b study in ... See all stories on this topic » | ||
| Transcept Pharmaceuticals Appoints John Kollins as Senior Vice President and ... Sacramento Bee By Transcept Pharmaceuticals, Inc. POINT RICHMOND, Calif., June 4, 2012 -- /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that ... See all stories on this topic » | ||
| Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company to ... MarketWatch (press release) RIDGEFIELD, Conn., and INDIANAPOLIS, June 5, 2012 /PRNewswire via COMTEX/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company (NYSE:LLY) are pleased to announce that less than two years after forming a strategic alliance aimed at ... See all stories on this topic » | ||
| Pharmaceutical company opens HQ in Chicago suburb BusinessWeek Astellas is one of Japan's largest pharmaceutical companies. The Glenview-based site is a US affiliate of Tokyo-based Astellas Pharma Inc. Japan's largest drug-maker is Takeda, which also has its North American headquarters in suburban Chicago. See all stories on this topic » | ||
| Hobart Group Holdings and AnswerLab Team Up To Offer Cutting Edge Digital ... MarketWatch (press release) The partnership is designed to help pharmaceutical manufacturers build great user experiences across digital platforms, improving how they interact with key customers across the managed markets spectrum. "We realized that our clients are rapidly ... See all stories on this topic » | ||
| Teva Pharmaceutical Industries Ltd Stock Downgraded (TEVA) TheStreet.com By TheStreet Wire 06/05/12 - 05:01 AM EDT NEW YORK (TheStreet) -- Teva Pharmaceutical Industries (NYSE:TEVA) has been downgraded by TheStreet Ratings from buy to hold. The company's strengths can be seen in multiple areas, such as its robust revenue ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment